- Home
- BDL vs LVTX Comparison
BDL vs LVTX Comparison
Compare BDL & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- LVTX
- Stock Information
- Founded
- BDL 1959
- LVTX 2016
- Country
- BDL United States
- LVTX Netherlands
- Employees
- BDL N/A
- LVTX N/A
- Industry
- BDL Restaurants
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- BDL Consumer Discretionary
- LVTX Health Care
- Exchange
- BDL Nasdaq
- LVTX Nasdaq
- Market Cap
- BDL 60.8M
- LVTX 33.9M
- IPO Year
- BDL N/A
- LVTX 2021
- Fundamental
- Price
- BDL $33.25
- LVTX $1.37
- Analyst Decision
- BDL
- LVTX Hold
- Analyst Count
- BDL 0
- LVTX 3
- Target Price
- BDL N/A
- LVTX $1.75
- AVG Volume (30 Days)
- BDL 1.9K
- LVTX 10.9K
- Earning Date
- BDL 08-12-2025
- LVTX 08-19-2025
- Dividend Yield
- BDL 1.48%
- LVTX N/A
- EPS Growth
- BDL 14.76
- LVTX N/A
- EPS
- BDL 2.18
- LVTX N/A
- Revenue
- BDL $198,785,000.00
- LVTX $4,990,000.00
- Revenue This Year
- BDL N/A
- LVTX N/A
- Revenue Next Year
- BDL N/A
- LVTX N/A
- P/E Ratio
- BDL $15.26
- LVTX N/A
- Revenue Growth
- BDL 9.31
- LVTX N/A
- 52 Week Low
- BDL $22.61
- LVTX $0.85
- 52 Week High
- BDL $35.98
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- BDL 60.35
- LVTX 60.82
- Support Level
- BDL $30.11
- LVTX $1.27
- Resistance Level
- BDL $34.70
- LVTX $1.40
- Average True Range (ATR)
- BDL 0.85
- LVTX 0.05
- MACD
- BDL 0.06
- LVTX 0.00
- Stochastic Oscillator
- BDL 68.77
- LVTX 73.08
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.